您的位置: 首页 > 农业专利 > 详情页

NEUARTIGES REBAMIPID-PRODRUG, VERFAHREN ZUR HERSTELLUNG DAVON UND VERWENDUNG DAVON
专利权人:
SAMJIN PHARMACEUTICAL CO.;SAMJIN PHARMACEUTICAL CO., LTD.; LTD.;ASTECH. CO., LTD.
发明人:
CHO, EUI-HWAN,CHOI, SUNG JU,LEE, SUNG WOO,SHIN, HEE JONG,KWON, HO SEOK,LEE, JAE WOONG,JOO, JEONG HO,KIM, HYUN TAE,SONG, WOO HEON,YOON, JONG BAE,PARK, KI SEOK,PARK, HO JOON,NAM, HO TAE
申请号:
EP13809037
公开号:
EP2865669A4
申请日:
2013.06.26
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
Disclosed are a novel rebamipide prodrug, a method for preparing the same, and use thereof. Also, a pharmaceutical composition comprising the novel rebamipide prodrug as an active ingredient is provided. The rebamipide prodrug is increased 25-fold in absorption rate compared to rebamipide itself, and can be applied to the prophylaxis or therapy of gastric ulcer, acute gastritis, chronic gastritis, xerophthalmia, cancer, osteoarthritis, rheumatoid arthritis, or obesity.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充